BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/05/2026

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of Cancer

The National Cancer Institute is considering granting an Exclusive Patent License to OncoVanta Therapeutics, Inc. for the development and commercialization of engineered cell therapies for cancer treatment.

Source: Federal Register — Health and Human ServicesOpen original release →